Freestone Capital Holdings’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
29,823
+7,242
| +32% | +$632K | 0.09% | 146 |
|
|
2025
Q1 | $1.54M | Sell |
22,581
-199
| -0.9% | -$13.6K | 0.06% | 180 |
|
|
2024
Q4 | $1.77M | Buy |
22,780
+3,637
| +19% | +$283K | 0.06% | 169 |
|
|
2024
Q3 | $1.28M | Buy |
19,143
+4,024
| +27% | +$270K | 0.04% | 190 |
|
|
2024
Q2 | $1.71M | Buy |
15,119
+884
| +6% | +$100K | 0.06% | 171 |
|
|
2024
Q1 | $1.97M | Buy |
14,235
+630
| +5% | +$87.4K | 0.07% | 165 |
|
|
2023
Q4 | $1.69M | Buy |
13,605
+437
| +3% | +$54.2K | 0.08% | 167 |
|
|
2023
Q3 | $1.23M | Buy |
13,168
+2,985
| +29% | +$279K | 0.07% | 161 |
|
|
2023
Q2 | $1.31M | Buy |
10,183
+117
| +1% | +$15K | 0.05% | 168 |
|
|
2023
Q1 | $1.17M | Sell |
10,066
-100
| -1% | -$11.6K | 0.05% | 178 |
|
|
2022
Q4 | $1.15M | Sell |
10,166
-195
| -2% | -$22.1K | 0.05% | 178 |
|
|
2022
Q3 | $834K | Sell |
10,361
-619
| -6% | -$49.8K | 0.04% | 214 |
|
|
2022
Q2 | $818K | Sell |
10,980
-1,236
| -10% | -$92.1K | 0.03% | 222 |
|
|
2022
Q1 | $1.56M | Buy |
12,216
+5,340
| +78% | +$683K | 0.06% | 209 |
|
|
2021
Q4 | $923K | Buy |
6,876
+1,188
| +21% | +$159K | 0.04% | 241 |
|
|
2021
Q3 | $778K | Buy |
+5,688
| New | +$778K | 0.04% | 240 |
|
|
2021
Q1 | – | Sell |
-460
| Closed | -$42.5K | – | 579 |
|
|
2020
Q4 | $42.5K | Buy |
460
+224
| +95% | +$20.7K | ﹤0.01% | 603 |
|
|
2020
Q3 | $24.3K | Buy |
+236
| New | +$24.3K | ﹤0.01% | 613 |
|